U.S. Abbvie, Lionsgate Studios, UnitedHealth Group
June 5 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Abbvie, Lionsgate Studios and UnitedHealth Group, on Wednesday.
HIGHLIGHTS
* Abbvie Inc ABBV.N: HSBC raises to buy from hold |
* Crowdstrike Holdings Inc CRWD.O: BTIG cuts target price to $402 from $432 |
* Lionsgate Studios LION.O: Seaport Research Partners initiates coverage with neutral rating |
* Sunoco LP SUN.N: JP Morgan assumes coverage with overweight vs neutral rating |
* UnitedHealth Group Inc UNH.N: HSBC raises to buy from hold |
Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.
* Abbvie Inc ABBV.N: HSBC raises target price to $185 from $161 |
* Abbvie Inc ABBV.N: HSBC raises to buy from hold |
* Adobe Inc ADBE.O: RBC cuts target price to $600 from $630 |
* Air Products and Chemicals Inc APD.N: Morgan Stanley raises PT to $280 from $240 |
* Alnylam Pharmaceuticals Inc ALNY.O: JP Morgan cuts target price to $160 from $166 |
* American Financial Group Inc AFG.N: Citigroup cuts target price to $144 from $145 |
* Annexon Inc ANNX.O: JP Morgan raises target price to $12 from $11 |
* Applied Materials Inc AMAT.O: Barclays raises target price to $225 from $165 |
* Applied Materials Inc AMAT.O: Barclays raises to equal-weight from underweight |
* Aramark ARMK.N: Jefferies raises target price to $37 from $35 |
* Aris Water Solutions Inc ARIS.N: Citigroup raises target price to $18 from $14 |
* Aspen Aerogels Inc ASPN.N: TD Cowen raises target price to $36 from $30 |
* Axsome Therapeutics Inc AXSM.O: RBC raises target price to $130 from $127 |
* Bath & Body Works Inc BBWI.N: BMO raises target price to $55 from $50 |
* Boot Barn Holdings Inc BOOT.N: BTIG raises target price to $150 from $125 |
* Boot Barn Holdings Inc BOOT.N: Craig-Hallum raises target price to $150 from $120 |
* Boot Barn Holdings Inc BOOT.N: TD Cowen raises target price to $145 from $120 |
* Boston Beer Company Inc SAM.N: Morgan Stanley raises to equal-weight from underweight |
* Braze Inc BRZE.O: Citigroup cuts target price to $52 from $65 |
* Bridgebio pharma Inc BBIO.O: JP Morgan raises target price to $46 from $44 |
* Citi Trends, Inc CTRN.O: Craig-Hallum cuts target price to $25 from $27 |
* Conocophillips COP.N: Mizuho cuts target price to $132 from $142 |
* Core & Main Inc CNM.N: Truist Securities cuts target price to $50 from $56 |
* Crowdstrike Holdings Inc CRWD.O: Bernstein cuts target price to $381 from $397 |
* Crowdstrike Holdings Inc CRWD.O: BMO cuts target price to $410 from $425 |
* Crowdstrike Holdings Inc CRWD.O: BTIG cuts target price to $402 from $432 |
* Crowdstrike Holdings Inc CRWD.O: Canaccord Genuity raises PT to $405 from $400 |
* Crowdstrike Holdings Inc CRWD.O: D.A. Davidson cuts target price to $380 from $425 |
* Crowdstrike Holdings Inc CRWD.O: Mizuho cuts target price to $370 from $390 |
* Crowdstrike Holdings Inc CRWD.O: Scotiabank cuts target price to $393 from $400 |
* Crowdstrike Holdings Inc CRWD.O: Wedbush cuts target price to $385 from $390 |
* Crowdstrike Holdings Inc CRWD.O: Oppenheimer raises target price to $400 from $355 |
* Darden Restaurants Inc DRI.N: Citigroup cuts target price to $191 from $192 |
* Designer Brands Inc DBI.N: Telsey Advisory Group cuts target price to $10 from $11 |
* Docusign Inc DOCU.O: Citigroup cuts target price to $86 from $93 |
* Donaldson Company Inc DCI.N: Jefferies raises target price to $81 from $77 |
* Entergy Corp ETR.N: Wells Fargo raises target price to $125 from $122 |
* Entergy Corp ETR.N: Barclays raises target price to $116 from $107 |
* Evgo Inc EVGO.O: Benchmark initiates coverage with buy rating; target price $3 |
* Factset Research Systems Inc FDS.N: Jefferies cuts target price to $378 from $455 |
* Ferguson FERG.N: Barclays cuts target price to $232 from $236 |
* Ferguson FERG.N: Jefferies cuts target price to $238 from $244 |
* Ferguson FERG.N: RBC cuts target price to $211 from $217 |
* Glaukos Corp GKOS.N: Stifel raises target price to $130 from $110 |
* Guidewire Software Inc GWRE.N: BofA Global Research raises price objective to $95 from $80 |
* Guidewire Software Inc GWRE.N: BTIG raises target price to $140 from $135 |
* Guidewire Software Inc GWRE.N: Citigroup raises target price to $123 from $122 |
* Guidewire Software Inc GWRE.N: JP Morgan raises target price to $145 from $133 |
* Guidewire Software Inc GWRE.N: Raymond James raises target price to $130 from $125 |
* Guidewire Software Inc GWRE.N: Stifel raises target price to $140 from $130 |
* Guidewire Software Inc GWRE.N: Wells Fargo raises target price to $140 from $130 |
* Guidewire Software Inc GWRE.N: Oppenheimer raises target price to $140 from $130 |
* Healthequity Inc HQY.O: Deutsche Bank raises target price to $102 from $95 |
* Hewlett Packard Enterprise HPE.N: Morgan Stanley raises PT to $21.00 from $19.00 |
* Hewlett Packard Enterprise Co HPE.N: Bernstein raises target price to $19 from $17 |
* Hewlett Packard Enterprise Co HPE.N: BofA Global Research raises price objective to $22 from $19 |
* Hewlett Packard Enterprise Co HPE.N: Evercore ISI raises target price to $22 from $18 |
* Hewlett Packard Enterprise Co HPE.N: Morgan Stanley raises target price to $21 from $19 |
* Hewlett Packard Enterprise Co HPE.N: Raymond James raises target price to $23 from $19 |
* Hewlett Packard Enterprise Co HPE.N: Stifel raises target price to $22 from $18 |
* Hewlett Packard Enterprise Co HPE.N: Susquehanna raises target price to $20 from $14 |
* Hewlett Packard Enterprise Co HPE.N: Wells Fargo raises target price to $22 from $19 |
* Hewlett Packard Enterprise Co HPE.N: Barclays raises target price to $20 from $14 |
* Honeywell International Inc HON.O: Daiwa Capital Markets raises PT to $217 from $200 |
* Hookipa pharma Inc HOOK.O: H.C. Wainwright raises target price to $6 from $5 |
* Hyster-Yale Inc HY.N: Northland Capital raises to outperform from market perform |
* Ideaya Biosciences Inc IDYA.O: JP Morgan raises target price to $65 from $55 |
* Illinois Tool Works Inc ITW.N: JP Morgan cuts target price to $275 from $280 |
* Insmed Inc INSM.O: Stifel raises target price to $74 from $67 |
* Ionis Pharmaceuticals Inc IONS.O: JP Morgan cuts target price to $50 from $55 |
* Keurig DR Pepper Inc KDP.O: Wells Fargo raises target price to $41 from $39 |
* Kla Corporation KLAC.O: Barclays raises target price to $765 from $630 |
* Kla Corporation KLAC.O: Barclays raises to equal-weight from underweight |
* Labcorp LH.N: HSBC cuts target price to $210 from $225 |
* Lam Research Corporation LRCX.O: Barclays raises target price to $900 from $865 |
* Leonardo Drs Inc DRS.O: Truist Securities raises target price to $27 from $25 |
* Lifemd Inc LFMD.O: KeyBanc initiates coverage with overweight rating and PT $12 |
* Lionsgate Studios LION.O: Seaport Research Partners initiates coverage with neutral rating |
* Magnite Inc MGNI.O: RBC raises target price to $19 from $17 |
* Mainz Biomed NV MYNZ.O: Jonestrading cuts target price to $4 from $8 |
* Marathon Oil Corp MRO.N: Mizuho raises target price to $34 from $33 |
* Medifast Inc MED.N: D.A. Davidson cuts target price to $17.5 from $25 |
* Medifast Inc MED.N: D.A. Davidson cuts to underperform from neutral |
* Merck & Co Inc MRK.N: HSBC raises target price to $130 from $118 |
* Meta META.O: Raymond James raises target price to $550 from $525 |
* Moog Inc MOGa.N: TD Cowen raises target price to $208 from $187 |
* Nextera Energy, Inc. NEE.N: Barclays raises target price to $74 from $66 |
* Old Dominion Freight Line Inc ODFL.O: BMO initiates coverage with outperform rating |
* Old Dominion Freight Line Inc ODFL.O: BMO initiates coverage with target price $210 |
* One Gas Inc OGS.N: Mizuho raises target price to $65 from $64 |
* Paylocity Holding Corp PCTY.O: Stifel cuts target price to $185 from $205 |
* PG&E Corporation PCG.N: Barclays raises target price to $22 from $21 |
* Phreesia Inc PHR.N: Jefferies cuts target price to $28 from $32 |
* Pinnacle West Capital Corp PNW.N: Wells Fargo raises target price to $80 from $77 |
* Procore Technologies Inc PCOR.N: Macquarie initiates coverage with neutral rating |
* Procore Technologies Inc PCOR.N: Macquarie initiates coverage with target price $70 |
* Progressive Corp PGR.N: Citigroup cuts target price to $230 from $232 |
* PVH Corp PVH.N: BMO raises target price to $119 from $110 |
* PVH Corp PVH.N: Evercore ISI raises target price to $145 from $140 |
* PVH Corp PVH.N: Wedbush raises target price to $143 from $128 |
* Root Inc ROOT.O: TD Cowen raises target price to $51 from $11 |
* Sensei Biotherapeutics Inc SNSE.O: Citigroup resumes coverage with buy rating; PT $4 |
* Sentinelone Inc S.N: Citigroup cuts target price to $20 from $25 |
* Siteone Landscape Supply Inc SITE.N: Barclays cuts target price to $129 from $133 |
* Siteone Landscape Supply Inc SITE.N: Barclays cuts target price to $129 from $133 |
* Snowflake Inc SNOW.N: Mizuho cuts target price to $180 from $205 |
* Snowflake Inc SNOW.N: RBC cuts target price to $183 from $226 |
* Spire Global Inc SPIR.N: Craig-Hallum initiates coverage with buy rating |
* Spire Global Inc SPIR.N: Craig-Hallum initiates coverage with target price $13 |
* Sportsmans Warehouse Holdings Inc SPWH.O: Craig-Hallum cuts target price to $4 from $5 |
* Steven Madden Ltd SHOO.O: Jefferies raises target price to $42 from $39 |
* Stitch Fix Inc SFIX.O: Truist Securities raises target price to $4 from $3.50 |
* Sunoco LP SUN.N: JP Morgan assumes coverage with overweight vs neutral rating |
* Sunoco LP SUN.N: JP Morgan assumes coverage with target price $61 vs $60 |
* Thor Industries Inc THO.N: CFRA cuts target price to $90 from $100 |
* U.S. Goldmining Inc. USGO.O: H.C. Wainwright raises target price to $23.5 from $23 |
* UnitedHealth Group Inc UNH.N: HSBC raises target price to $580 from $460 |
* UnitedHealth Group Inc UNH.N: HSBC raises to buy from hold |
* Verint Systems Inc VRNT.O: Jefferies raises target price to $32 from $30 |
* Viasat VSAT.O: Barclays cuts target price to $24 from $28 |
* Viking Therapeutics Inc VKTX.O: Leerink Partners raises PT to $118 from $115 |
* Vir Biotechnology Inc VIR.O: JP Morgan raises target price to $13 from $12 |
* Zscaler Inc ZS.O: Citigroup cuts target price to $240 from $270 |
(Compiled by Bengaluru Newsroom)
</body></html>Похожие активы
Последние новости
Правовая оговорка: Компании группы XM Group предоставляют только услуги по исполнению сделок и доступ к нашей торговой онлайн-среде, в которой пользователи могут просматривать и (или) пользоваться материалами, доступными на вебсайте либо доступными по ссылкам с данного сайта на другие. Предоставление доступа к онлайн-среде не меняет сути предоставляемых услуг и не расширяет их. Такой доступ и пользование материалами предоставляются с учетом:(i) «Условий и положений»; (ii) «Предупреждений о рисках» и (iii) полного текста «Правовой оговорки». Следовательно, подобные материалы предоставляются лишь в качестве информации общего характера. В частности, просим Вас иметь в виду, что материалы, содержащиеся в нашей торговой онлайн-среде, не являются ни просьбой осуществить какие-либо транзакции на финансовых рынках, ни предложением к осуществлению подобных транзакций. Торговля на любом финансовом рынке подразумевает большой риск потери Вашего капитала.
Все материалы, опубликованные в нашей торговой среде, предоставляются только в образовательных или информационных целях и не содержат (и не должны рассматриваться как содержащие) финансовых, инвестиционных или торговых рекомендаций, а также информации о стоимости наших услуг по предоставлению доступа к рынкам, либо предложения или содействия в проведении транзакций по какому-либо финансовому инструменту или по незапрашиваемым финансовым услугам по отношению к Вам.
Любые материалы на данном вебсайте, созданные третьими лицами, а также материалы, подготовленные XM, такие как мнения экспертов, новости, исследования, анализ, котировки и другая информация, а также ссылки на сторонние сайты предоставляются в виде «как есть», как рыночная информация общего характера, и не являют собой рекомендации по инвестициям. Принимая во внимание то, что любые материалы рассматриваются как инвестиционное исследование, Вам следует учесть и принять тот факт, что никакие материалы не подготавливались и не предназначались к использованию в соответствии с правовыми нормами, способствующими независимости инвестиционных исследований. Следовательно, материалы следует рассматривать как материалы рекламного характера согласно соответствующим законам и правовым нормам. Рекомендуем Вам прочесть и уяснить для себя положения наших «Уведомления о субъективном инвестиционном исследовании» и «Предупреждения о рисках» в отношении приведённой выше информации. С этими документами можно ознакомиться здесь.